Cargando…
Clinicopathological and immunological characterization of RNA m(6)A methylation regulators in ovarian cancer
BACKGROUND: N(6)‐methyladenosine (m(6)A) modification is one of the critical gene regulatory mechanisms implicated in cancer biology. However, the roles of m(6)A regulators in ovarian cancer are still poorly understood. METHODS: We integrated multiple databases including Gene Expression Omnibus (GEO...
Autores principales: | Wang, Qingying, Zhang, Qinyi, Li, Qingxian, Zhang, Jing, Zhang, Jiawen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963423/ https://www.ncbi.nlm.nih.gov/pubmed/33225598 http://dx.doi.org/10.1002/mgg3.1547 |
Ejemplares similares
-
ACTL6A regulates follicle-stimulating hormone-driven glycolysis in ovarian cancer cells via PGK1
por: Zhang, Jiawen, et al.
Publicado: (2019) -
Association Between Succinate Receptor SUCNR1 Expression and Immune Infiltrates in Ovarian Cancer
por: Zhang, Jiawen, et al.
Publicado: (2020) -
RNA m6A methylation regulators in ovarian cancer
por: Guo, Jialu, et al.
Publicado: (2021) -
m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer
por: Zhang, Cheng, et al.
Publicado: (2021) -
Changes in m(6)A RNA methylation are associated with male sterility in wolfberry
por: Zhao, Jiawen, et al.
Publicado: (2023)